Alcohol-related diseases and injuries have the potential to cost the Australian healthcare system a staggering $68 billion over 60 years if nothing is done to stop the impact. The new Griffith ...
Alcohol use disorder (AUD) remains a major public health challenge in the United States, contributing to more than 170,000 ...
John Quiggin does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...
Milad Haghani receives funding from The Australian Office of Road Safety. Australia has made major progress in curbing drink driving. Decades of random breath testing, enforcement and powerful social ...
Several research studies, either in progress or in planning stages, are testing whether GLP-1 agonists can help people who have symptoms of an alcohol use disorder reduce drinking. The goal of the ...
What began as an unexpected observation and “side effect” of some medications converged with decades of addiction neuroscience: GLP-1 receptor agonist medications like Ozempic apparently reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results